CollPlant Biotechnologies Ltd (CLGN) Deferred Tax Assets, Tax Deferred Expense, Other

Prices Financial Statements ›Discontinued ›News Ratios Analyst Ratings Insider Transactions SEC Filings Roast Me Breakdown

Balance Sheet ›Income Statement ›Expense Statement ›Cash Flow ›Dividends, Cash Notes ›

Concentration Risk, Percentage Receivables ›Inventory ›Lessee, Operating Lease, Liability, to be Paid, after Year Five Debt ›Class of Warrant or Right, Outstanding Equity ›Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination Compensation Related Costs ›Income Taxes ›Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Number of Reportable Segments Accounts Payable, Fair Value Disclosure Termination Loans Purchase Options, Land Acquisitiondate Fair Value Of Total Consideration Transferred Additional Paid in Capital Derivative Instruments and Hedging Activities ›Adjustments For Increase Decrease In Other Liabilities Adjustments For Increase Decrease In Other Operating Payables Adjustments For Increase Decrease In Trade Account Payable Adjustments For Increase Decrease In Trade And Other Payables Applicable Tax Rate Assets Cash Flows From Used In Increases In Operating Capacity Cash Flows From Used In Operations Cash Flows From Used In Operations Before Changes In Working Capital Leases ›Cash Transferred Computer Software Current Assets Current Contract Liabilities Current Liabilities Deferred Income Classified As Current Deferred Income Classified As Noncurrent Description Of Expected Volatility Share Options Granted Description Of Risk Free Interest Rate Share Options Granted Equity Equity And Liabilities Finished Goods Fixtures And Fittings Increase Decrease Through Conversion Of Convertible Instruments Increase Decrease Through Exercise Of Options Increase Decrease Through Exercise Of Warrants Equity Intangible Assets ›Investment Property Issue Of Convertible Instruments Issued Capital Liabilities Longterm Borrowings Motor Vehicles Noncurrent Assets Noncurrent Contract Liabilities Noncurrent Debt Instruments Issued Noncurrent Financial Liabilities Noncurrent Government Grants Noncurrent Liabilities Number Of Instruments Or Interests Issued Or Issuable Shares ›Office Equipment Other Current Payables Other Liabilities Owneroccupied Property Measured Using Investment Property Fair Value Model Par Value Per Share Prepayments Reimbursement Rights At Fair Value Reserve Of Exchange Differences On Translation Retained Earnings Rightofuse Assets Tax Rate Effect From Change In Tax Rate Trade And Other Current Payables Trade And Other Current Payables To Trade Suppliers Transfers Of Research And Development From Entity Related Party Transactions Value Added Tax Payables Vehicles Wages And Salaries Work In Progress

Deferred Tax Assets, Net of Valuation Allowance ›Operating Loss Carryforwards Increase Decrease In Deferred Tax Liability Asset

Gross ›Total

Operating Loss Carryforwards, Domestic Tax Deferred Expense ›

Compensation and Benefits Other

CollPlant Biotechnologies Ltd Deferred Tax Assets, Tax Deferred Expense, Other

CollPlant Biotechnologies Ltd (CLGN) had Deferred Tax Assets, Tax Deferred Expense, Other of $230.00 thousand as of 2022-12-31, per its 20-F filed 2024-04-04.

Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense

us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2024-04-04

2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $230.00K.

Period end	Deferred Tax Assets, Tax Deferred Expense, Other
2022-12-31	$230.00K 20-F · filed 2024-04-04